NAVIDEA BIOPHARMACEUTICALS
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) focuses on the development of innovative immunodiagnostic agents and immunotherapeutics to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Patients and physicians, aspire to provide innovative immunodiagnostic agents and therapies to improve patient care for serious diseases. For investors, they aim to deliver superior growth through t... heir focus on developing their innovative Manocept™ platform and driving efficient business processes. For their employees, they provide a culture that focuses on the direct contributions their efforts make for the patients they serve and an innovative development environment for new breakthrough products.
NAVIDEA BIOPHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Health Diagnostics
Founded:
1983-01-01
Address:
Dublin, Ohio, United States
Country:
United States
Website Url:
http://www.navidea.com
Total Employee:
11+
Status:
Active
Contact:
614-822-2373
Email Addresses:
[email protected]
Total Funding:
101 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2001-12-01 | Cardiosonix | Cardiosonix acquired by Navidea Biopharmaceuticals | N/A |
Investors List
John K. Scott
John K. Scott investment in Post-IPO Debt - Navidea Biopharmaceuticals
John K. Scott
John K. Scott investment in Post-IPO Equity - Navidea Biopharmaceuticals
CRG
CRG investment in Post-IPO Debt - Navidea Biopharmaceuticals
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Navidea Biopharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-27 | Navidea Biopharmaceuticals Appoints Michel Mikhail, Ph.D. as Chief Regulatory Officer |
Official Site Inspections
http://www.navidea.com Semrush global rank: 4.99 M Semrush visits lastest month: 1.69 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Navidea Biopharmaceuticals"
Navidea Biopharmaceuticals, Inc. (NAVB)
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected …See details»
Company Information :: Navidea Biopharmaceuticals, …
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, …See details»
Navidea Biopharmaceuticals, Inc. (NAVB) Company Profile
Nov 8, 2024 · Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and …See details»
Navidea Biopharmaceuticals - Crunchbase Company Profile
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) focuses on the development of innovative immunodiagnostic agents and immunotherapeutics to enhance patient care by identifying the …See details»
Navidea Biopharmaceuticals, Inc. (NAVB) - Yahoo Finance
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates in two...See details»
Org Chart Navidea Biopharmaceuticals - The Official Board
The organizational chart of Navidea Biopharmaceuticals displays its 7 main executives including Craig Dais and Michael Sherman Toggle navigation The Official Board SearchSee details»
Navidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts ...
May 8, 2023 · G2G Ventures, executive consultants to Navidea, with demonstrated expertise in building infrastructure, rigorous process, and proven growth strategies, is supporting the …See details»
Navidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts ...
May 8, 2023 · Navidea is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of disease and enable …See details»
Navidea Biopharmaceuticals, Inc. Reports First Quarter 2023 …
Following recently reported financial results for its first quarter ending March 31, 2023, the Company provides additional insight on performance and objectives in line with its Fix, Fund, …See details»
About :: Navidea Biopharmaceuticals, Inc. (NAVB)
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected …See details»
Investor Relations :: Navidea Biopharmaceuticals, Inc. (NAVB)
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected …See details»
Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces …
DUBLIN, Ohio-- (BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision …See details»
NAVB Stock Price Quote | Morningstar
6 days ago · See the latest Navidea Biopharmaceuticals Inc stock price (NAVB:PINX), related news, valuation, dividends and more to help you make your investing decisions.See details»
Navidea Biopharmaceuticals Adds New Member to Board of …
Navidea is developing multiple precision diagnostic products and platforms including NAV4694, NAV5001, Manocept™ and NAV1800 (RIGScan™), to help identify the sites and pathways of …See details»
Navidea Biopharmaceuticals - Overview, News & Similar
Navidea Biopharmaceuticals contact info: Phone number: (614) 793-7500 Website: www.navidea.com What does Navidea Biopharmaceuticals do? Navidea Biopharmaceuticals, …See details»
Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial ...
Mar 23, 2022 · Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents …See details»
Board of Directors :: Navidea Biopharmaceuticals, Inc. (NAVB)
John K. Scott, Jr. joined the Board of Navidea as a Director in July of 2021. Mr. Scott has also served as the owner and manager of PCS, Inc. since 1997, where he is responsible for …See details»
Court backs Texas over razor wire installed on U.S.-Mexico border
13 hours ago · A federal appeals court Wednesday ruled that Border Patrol agents cannot cut razor wire that Texas installed on the U.S.-Mexico border in the town of Eagle Pass, Texas.See details»
Navidea Biopharmaceuticals Announces Business Update Call and …
A live audio webcast of the conference call will also be available on the investor relations page of Navidea’s corporate website at www.navidea.com. In addition, the recorded conference call …See details»
Navidea Biopharmaceuticals Reports Third Quarter 2021 Financial …
Nov 10, 2021 · DUBLIN, Ohio-- (BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of …See details»